Peptide Science research editorial team.
Bronchogen 20mg (Bioregulator) Overview
Bronchogen 20mg from Peptide Science is the synthetic Khavinson short-peptide bioregulator derived from bronchial-mucosal tissue fractions, supplied as a lyophilised vial for in-vitro and preclinical respiratory-cell and pulmonary-research applications. The compound is one of the bronchopulmonary-system-targeted members of the Khavinson short-peptide family.
Khavinson Short-Peptide Class Background
Bronchogen belongs to the Khavinson short-peptide family, a class of synthetic two-to-four-residue peptides originally derived from bioregulator-fraction extracts of mammalian tissues by V. Kh. Khavinson and colleagues from the 1980s onward. The class is characterised by short sequence length, organ-specific source-tissue derivation, and synthetic reconstitution of the original tissue-fraction activity. The bronchopulmonary subset of the family includes Bronchogen alongside the related Chonluten bronchial-mucosal bioregulator.
Bronchopulmonary Bioregulator Research Context
Bronchogen is studied in preclinical research for bronchial-epithelial cell signalling pathways and lower-respiratory-tract mucosal-research models, with reported research interest in inflammatory and barrier-function pathways in cultured respiratory cells. The compound complements Chonluten in the bronchopulmonary research subset of the Khavinson family, supporting comparative studies across two distinct bronchial-tissue-derived bioregulators. Browse the broader bioregulator peptide range.
Vial Specifications
| Property | Value |
|---|---|
| Compound | Bronchogen |
| Class | Khavinson short-peptide bioregulator |
| Source-tissue derivation | Bronchial-mucosal tissue fraction |
| Supplied form | Lyophilised powder, sealed vial |
| Strength | 20 mg per vial |
| Purity | greater than 99 percent (HPLC verified) |
| Storage | 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term |
For the related bronchopulmonary Khavinson bioregulator, see Chonluten 20mg.
Reconstitution and Handling
The lyophilised short peptide reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard handling practice cited in Khavinson-tradition research protocols.
Quality and Shipping
Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging.
For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.
Reviews
There are no reviews yet.